SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-028617
Filing Date
2016-11-09
Accepted
2016-11-09 16:07:14
Documents
56
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pbyi-10q_20160930.htm 10-Q 1437567
2 EX-10.1 pbyi-ex101_197.htm EX-10.1 10176
3 EX-31.1 pbyi-ex311_10.htm EX-31.1 11938
4 EX-31.2 pbyi-ex312_11.htm EX-31.2 11954
5 EX-32.1 pbyi-ex321_6.htm EX-32.1 8902
6 EX-32.2 pbyi-ex322_9.htm EX-32.2 9039
  Complete submission text file 0001564590-16-028617.txt   5566247

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT pbyi-20160930.xml EX-101.INS 1304449
8 XBRL TAXONOMY EXTENSION SCHEMA pbyi-20160930.xsd EX-101.SCH 34742
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbyi-20160930_cal.xml EX-101.CAL 33709
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbyi-20160930_def.xml EX-101.DEF 120319
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbyi-20160930_lab.xml EX-101.LAB 302494
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbyi-20160930_pre.xml EX-101.PRE 249760
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35703 | Film No.: 161984261
SIC: 2834 Pharmaceutical Preparations